Index of reports
> Cases with Death (11)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mozobil (Plerixafor Subcutaneous) where reactions include death. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-06-01
Patient: female, weighing 73.8 kg (162.4 pounds)
Reactions: Death, Therapeutic Response Decreased, Upper Respiratory Tract Infection, Influenza
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mozobil
Dosage: 320 mcg/kg, once
Start date: 2011-01-13
End date: 2011-01-13
Mozobil
Dosage: 320 mcg/kg, once
Start date: 2011-01-16
End date: 2011-01-16
Bortezomib
Dosage: 1.3 mg/m2, once
Indication: Multiple Myeloma
Start date: 2011-01-06
End date: 2011-01-06
Mozobil
Dosage: 320 mcg/kg, once
Start date: 2011-02-06
End date: 2011-02-06
Mozobil
Dosage: 320 mcg/kg, once
Indication: Multiple Myeloma
Start date: 2011-01-09
End date: 2011-01-09
Bortezomib
Dosage: 1.3 mg/m2, once
Start date: 2011-01-09
End date: 2011-01-09
Bortezomib
Dosage: 1.3 mg/m2, once
Start date: 2011-01-13
End date: 2011-01-13
Mozobil
Dosage: 320 mcg/kg, qd
Indication: Haematopoietic Stem Cell Mobilisation
Start date: 2011-01-04
End date: 2011-01-06
Bortezomib
Dosage: 1.3 mg/m2, once
Start date: 2011-01-16
End date: 2011-01-16
Bortezomib
Dosage: 1.3 mg/m2, once
Start date: 2011-02-06
End date: 2011-02-06
Other drugs received by patient: Advair Diskus 100 / 50; Norvasc; Albuterol; Zithromax
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-05-11
Patient: female, weighing 73.8 kg (162.4 pounds)
Reactions: Death, Therapeutic Response Decreased, Upper Respiratory Tract Infection, Influenza
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mozobil
Dosage: 320 mcg/kg, once
Start date: 2011-02-06
End date: 2011-02-06
Bortezomib
Dosage: 1.3 mg/m2, once
Indication: Multiple Myeloma
Start date: 2011-01-06
End date: 2011-01-06
Bortezomib
Dosage: 1.3 mg/m2, once
Start date: 2011-02-06
End date: 2011-02-06
Bortezomib
Dosage: 1.3 mg/m2, once
Start date: 2011-01-13
End date: 2011-01-13
Mozobil
Dosage: 320 mcg/kg, qd
Indication: Haematopoietic Stem Cell Mobilisation
Start date: 2011-01-04
End date: 2011-01-06
Mozobil
Dosage: 320 mcg/kg, once
Indication: Multiple Myeloma
Start date: 2011-01-09
End date: 2011-01-09
Mozobil
Dosage: 320 mcg/kg, once
Start date: 2011-01-16
End date: 2011-01-16
Bortezomib
Dosage: 1.3 mg/m2, once
Start date: 2011-01-16
End date: 2011-01-16
Mozobil
Dosage: 320 mcg/kg, once
Start date: 2011-01-13
End date: 2011-01-13
Bortezomib
Dosage: 1.3 mg/m2, once
Start date: 2011-01-09
End date: 2011-01-09
Other drugs received by patient: Albuterol; Norvasc; Zithromax; Advair Diskus 100 / 50
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-04-26
Patient: female, weighing 52.6 kg (115.7 pounds)
Reactions: Death, Systemic Mycosis, Adenovirus Infection, Osteomyelitis, Bone Marrow Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Cefepime; Hydrocortisone; Lorazepam; Ranitidine; Etoposide; Dapsone; Pantoprazole; Acetaminophen; Cytarabine; Enalapril Maleate; Diphenhydramine HCL; Hydroxyzine; Nifedipine; Ondansetron; Vancomycin
Possible Mozobil side effects in
Reported by a consumer/non-health professional from Germany on 2012-04-24
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Mozobil
Indication: Multiple Myeloma
Mozobil
Dosage: unk
Indication: Haematopoietic Stem Cell Mobilisation
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-04-19
Patient: female, weighing 73.8 kg (162.4 pounds)
Reactions: Death, Therapeutic Response Decreased, Upper Respiratory Tract Infection, Influenza
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mozobil
Dosage: 320 mcg/kg, once
Start date: 2011-02-06
End date: 2011-02-06
Mozobil
Dosage: 320 mcg/kg, once
Start date: 2011-01-16
End date: 2011-01-16
Bortezomib
Dosage: 1.3 mg/m2, once
Indication: Multiple Myeloma
Start date: 2011-01-06
End date: 2011-01-06
Bortezomib
Dosage: 1.3 mg/m2, once
Start date: 2011-01-16
End date: 2011-01-16
Mozobil
Dosage: 320 mcg/kg, once
Indication: Multiple Myeloma
Start date: 2011-01-09
End date: 2011-01-09
Mozobil
Dosage: 320 mcg/kg, once
Start date: 2011-01-13
End date: 2011-01-13
Bortezomib
Dosage: 1.3 mg/m2, once
Start date: 2011-01-13
End date: 2011-01-13
Mozobil
Dosage: 320 mcg/kg, qd
Indication: Haematopoietic Stem Cell Mobilisation
Start date: 2011-01-04
End date: 2011-01-06
Bortezomib
Dosage: 1.3 mg/m2, once
Start date: 2011-01-09
End date: 2011-01-09
Bortezomib
Dosage: 1.3 mg/m2, once
Start date: 2011-02-06
End date: 2011-02-06
Other drugs received by patient: Albuterol; Norvasc; Advair Diskus 100 / 50; Zithromax
Possible Mozobil side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-17
Patient: female, weighing 91.4 kg (201.1 pounds)
Reactions: Fluid Overload, Death, Lymphopenia, Opportunistic Infection, Febrile Neutropenia, Convulsion
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mozobil
Dosage: 240 mcg/kg, qd
Start date: 2011-12-05
End date: 2011-12-05
Mozobil
Dosage: 240 mcg/kg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2011-11-23
End date: 2011-11-23
Other drugs received by patient: Neupogen; Phenergan HCL; Fexofenadine W; Sodium Chloride; Sorafenib; ABH; Dilaudid; Lomotil; Zofran; Valtrex; Hydralazine HCL; Hydromorphone HCL; Sodium Chloride; Sodium Chloride; Neupogen; Cytarabine; Protonix; Toprol-XL; Triamcinolone; Dextromethorphan W; Ondansetron; Oyster Shell Calcium; Silver Sulfadiazine; Sodium Chloride; Albuterol; Ambien; Phenergan HCL; Zofran; Diovan HCT; Heparin Lock-Flush; Synthroid; Triamcinolone; Camphor W; Magnesium Sulfate; Potassium Chloride; Docusate Sodium W; Tramadol HCL; White Petroleum; Hycodan; Protonix; Vantin; Fluocinonide; Hydrocodone W; Hydromorphone HCL; Insulin Lispro; Linezolid; ABH; Acetaminophen; Cefepime Hydrochloride; Diphenhydramine HCL; Granisetron; Throat Preparations; Potassium Chloride; Xanax; Diovan HCT; Lantus; Magnesium; Potassium; Dextrose; Hydroxyzine; Insulin Lispro; Ondansetron; Docusate Sodium W; Vitamin TAB; Sucralfate; Tramadol HCL; Sorafenib; Tessalon; Effexor XR; Novolog; Vfend; Acetaminophen; Aluminium W; Cefepime Hydrochloride; Hydrocodone W; Hydrocortisone Sodium Succinate; Hydromorphone HCL; Magnesium Sulfate; Metoclopramide; Sodium Chloride
Possible Mozobil side effects in 74 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-09
Patient: 74 year old female, weighing 67.6 kg (148.7 pounds)
Reactions: Hypotension, Generalised Oedema, Splenic Infarction, Ascites, Death, Dehydration, Splenic Haemorrhage, Vascular Pseudoaneurysm, Splenomegaly, Splenic Rupture
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mozobil
Dosage: 22840 mcg, qd
Start date: 2012-01-31
End date: 2012-02-01
Mozobil
Dosage: 22840 mcg, qd
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-01-30
End date: 2012-01-30
Mozobil
Dosage: 13704 mcg, once
Indication: Haematopoietic Stem Cell Mobilisation
Start date: 2012-01-25
End date: 2012-01-25
Filgrastim
Dosage: 570 mcg, qd
Indication: Haematopoietic Stem Cell Mobilisation
Start date: 2012-01-25
End date: 2012-02-01
Other drugs received by patient: Miralax; Steroid Therapy; Vitamin D; Oxycodone HCL; Oxycodone HCL; Fluorodeoxyglucose F 18; Calcium; Colace
Possible Mozobil side effects in
Reported by a consumer/non-health professional from United States on 2011-12-14
Patient:
Reactions: Death, Restlessness, Nausea, Platelet Count Decreased, Neutrophil Count Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Cytarabine; Etoposide; Neupogen; Mitoxantrone
Possible Mozobil side effects in
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2011-10-31
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Neupogen
Possible Mozobil side effects in
Reported by a physician from Netherlands on 2011-10-19
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Neupogen
Possible Mozobil side effects in
Reported by a physician from Netherlands on 2011-10-04
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Neupogen
|